Change in quality of life differences from baseline to 2 months and follow-up (6 months)
| Within-group differences from baseline (95% CI) | Between-group differences | |||||
| HBPR (n=33) | Control (n=30) | HBPR minus control | ||||
| End rehabilitation (n=27) | 6 months (n=19) | End rehabilitation (n=28) | 6 months (n=18) | End rehabilitation | 6 months | |
| QoL-B (physical) | 10.30±18.05 (2.79–17.80)* | −10.11±18.78 (−18.26– −1.95)# | −1.15±20.73 (−8.66–6.36) | −1.76±15.94 (−10.39–6.86) | 11.44 (0.83–22.06)¶ | −8.34 (−20.21–3.53) |
| QoL-B (role) | 11.30±12.85 (4.84–17.76)* | −5.58±12.74 (−11.09– −0.07)# | −0.22±19.87 (−6.69–6.24) | −1.24±10.67 (−7.06–4.59) | 11.52 (2.38–20.66)¶ | −4.34 (−12.36–3.67) |
| QoL-B (vitality) | 0.37±15.90 (−5.85–6.59) | −11.79±16.74 (−19.18– −4.40)# | −1.00±16.29 (−7.22–5.22) | −2.24±14.81 (−10.05–5.58) | 1.37 (−7.42–10.16) | −9.55 (−20.31–1.21) |
| QoL-B (emotional) | 3.52±12.34 (−1.08–8.12) | −0.89±12.98 (−5.83–7.62) | −3.63±11.46 (−8.23–0.97) | −4.41±15.90 (−11.52–2.70) | 7.15 (0.65–13.65)¶ | 5.31 (−4.48–15.10) |
| QoL-B (social) | 1.26±26.41 (−7.83–10.35) | 1.68±17.82 (−7.24–10.61) | −3.41±20.28 (−12.50–5.68) | −0.06±20.53 (−9.49–9.38) | 4.67 (−8.19–17.52) | 1.74 (−11.24–14.73) |
| QoL-B (treatment burden) | −5.30±25.15 (−15.10–4.51) | 5.68±19.69 (−4.92–16.29) | −0.07±25.63 (−9.88–9.73) | −2.71±25.76 (−13.92–8.51) | −5.22 (−19.09–8.64) | 8.39 (−7.04–23.82) |
| QoL-B (health) | −2.63±17.71 (−9.05–3.79) | 9.84±18.64 (1.73–17.96)# | −1.15±15.44 (−7.57–5.26) | 8.65±15.91 (0.07–17.23)# | −1.48 (−10.56–7.59) | 1.20 (−10.62–13.01) |
| QoL-B (respiratory) | 3.04±11.31 (−1.93–8.00) | −4.68±11.33 (−10.26–0.89) | −0.56±14.23 (−5.52–4.41) | −7.88±2.62 (−13.78– −1.99)# | 3.59 (−3.43–10.61) | 3.20 (−4.91–11.31) |
Data are presented as mean±sd (95% CI). HBPR: home-based pulmonary rehabilitation; QoL-B: Quality of Life Questionnaire Bronchiectasis. *: p<0.05 versus baseline; #: p<0.05 versus end rehabilitation; ¶: p<0.05 between groups.